Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-005905

Corporate Executive VP & COO sold 3,205 shares at an average $254.39 ($815,310)

  • Corporate Executive VP & COO acquired 3,205 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Option exercise +3,205 $109.34 $350,435 44,243 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −84 $246.13 $20,675 44,159 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −100 $248.07 $24,807 44,059 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −73 $249.22 $18,193 43,986 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −78 $250.69 $19,554 43,908 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −183 $251.56 $46,035 43,725 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −157 $252.87 $39,700 43,568 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −219 $253.78 $55,578 43,349 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −417 $254.55 $106,147 42,932 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −1,392 $255.65 $355,870 41,540 D
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Sale −502 $256.48 $128,751 41,038 D
Derivatives
Girshick Birgit Corporate Executive VP & COO 2023-02-16 Option exercise · Stock Options (Right to Buy) −3,205 0 D
Open-market sales · 3,205 sh · avg $254.39 · $815,310
Loading xslF345X03/form4.xml…